IRBM, AACR

IRBM divulgará forte eficácia antitumoral de novos agentes pré-clínicos contra tumores cerebrais agressivos e leucemia linfoblástica aguda na AACR

07.08.2025 - 18:03:08

IRBM S.p.A. United Kingdom United States of America France Germany Spain Italy California

@ prnewswire.co.uk